BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 31510013)

  • 21. miRNA-99b-5p suppresses liver metastasis of colorectal cancer by down-regulating mTOR.
    Li W; Chang J; Wang S; Liu X; Peng J; Huang D; Sun M; Chen Z; Zhang W; Guo W; Li J
    Oncotarget; 2015 Sep; 6(27):24448-62. PubMed ID: 26259252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationships among
    Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
    World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases.
    Kahlert C; Klupp F; Brand K; Lasitschka F; Diederichs S; Kirchberg J; Rahbari N; Dutta S; Bork U; Fritzmann J; Reissfelder C; Koch M; Weitz J
    Cancer Sci; 2011 Oct; 102(10):1799-807. PubMed ID: 21722265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic microRNA expression signature from examination of colorectal primary and metastatic tumors.
    Ellermeier C; Vang S; Cleveland K; Durand W; Resnick MB; Brodsky AS
    Anticancer Res; 2014 Aug; 34(8):3957-67. PubMed ID: 25075017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and prediction of novel non-coding and coding RNA-associated competing endogenous RNA networks in colorectal cancer.
    Liang Y; Zhang C; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Dec; 24(46):5259-5270. PubMed ID: 30581274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and mechanism of microRNA-181A on incidence and survival in late liver metastases of colorectal cancer.
    Li Z; Wang H; Xu Z; Sun Y; Han J
    Oncol Rep; 2016 Mar; 35(3):1403-8. PubMed ID: 26750720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of miR‑221 and miR‑222 in the cancer stroma is associated with malignant potential in colorectal cancer.
    Iida M; Hazama S; Tsunedomi R; Tanaka H; Takenouchi H; Kanekiyo S; Tokumitsu Y; Tomochika S; Tokuhisa Y; Sakamoto K; Suzuki N; Takeda S; Ueno T; Yamamoto S; Yoshino S; Fujita K; Kuroda M; Nagano H
    Oncol Rep; 2018 Sep; 40(3):1621-1631. PubMed ID: 30015977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiRNA-21 Expression Decreases from Primary Tumors to Liver Metastases in Colorectal Carcinoma.
    Feiersinger F; Nolte E; Wach S; Rau TT; Vassos N; Geppert C; Konrad A; Merkel S; Taubert H; Stürzl M; Croner RS
    PLoS One; 2016; 11(2):e0148580. PubMed ID: 26845148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical response and prognostic significance of serum miR-497 expression in colorectal cancer.
    Zou G; Wang R; Wang M
    Cancer Biomark; 2019; 25(1):11-18. PubMed ID: 31006664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-124 reduces the pentose phosphate pathway and proliferation by targeting PRPS1 and RPIA mRNAs in human colorectal cancer cells.
    Qiu Z; Guo W; Wang Q; Chen Z; Huang S; Zhao F; Yao M; Zhao Y; He X
    Gastroenterology; 2015 Nov; 149(6):1587-1598.e11. PubMed ID: 26248089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer.
    Zhang Y; Guo L; Li Y; Feng GH; Teng F; Li W; Zhou Q
    Mol Cancer; 2018 Jan; 17(1):1. PubMed ID: 29304823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of miRNA-148a and miRNA-625-3p in colorectal cancer is associated with tumor budding.
    Baltruskeviciene E; Schveigert D; Stankevicius V; Mickys U; Zvirblis T; Bublevic J; Suziedelis K; Aleknavicius E
    BMC Cancer; 2017 Sep; 17(1):607. PubMed ID: 28863773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
    Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
    Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a metastasis-specific MicroRNA signature in human colorectal cancer.
    Hur K; Toiyama Y; Schetter AJ; Okugawa Y; Harris CC; Boland CR; Goel A
    J Natl Cancer Inst; 2015 Mar; 107(3):. PubMed ID: 25663689
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
    Gao S; Liu H; Hou S; Wu L; Yang Z; Shen J; Zhou L; Zheng SS; Jiang B
    Clin Transl Oncol; 2018 Jun; 20(6):703-712. PubMed ID: 29071516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating Exosomal MicroRNA-21 as a Biomarker in Each Tumor Stage of Colorectal Cancer.
    Tsukamoto M; Iinuma H; Yagi T; Matsuda K; Hashiguchi Y
    Oncology; 2017; 92(6):360-370. PubMed ID: 28376502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas.
    Gattolliat CH; Uguen A; Pesson M; Trillet K; Simon B; Doucet L; Robaszkiewicz M; Corcos L
    Eur J Cancer; 2015 Feb; 51(3):409-20. PubMed ID: 25586944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of miR-199b is associated with distant metastasis in colorectal cancer via activation of SIRT1 and inhibition of CREB/KISS1 signaling.
    Shen ZL; Wang B; Jiang KW; Ye CX; Cheng C; Yan YC; Zhang JZ; Yang Y; Gao ZD; Ye YJ; Wang S
    Oncotarget; 2016 Jun; 7(23):35092-105. PubMed ID: 27145368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating intra-tumor heterogeneity and expression gradients of miR-21, miR-92a and miR-200c and their potential of predicting lymph node metastases in early colorectal cancer.
    Jepsen RK; Novotny GW; Klarskov LL; Christensen IJ; Høgdall E; Riis LB
    Exp Mol Pathol; 2016 Oct; 101(2):187-196. PubMed ID: 27565378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-206 is an independent prognostic factor and inhibits tumor invasion and migration in colorectal cancer.
    Sun P; Sun D; Wang X; Liu T; Ma Z; Duan L
    Cancer Biomark; 2015; 15(4):391-6. PubMed ID: 26406866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.